Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI reads scans to spot hidden cancer spread

NCT ID NCT07183124

Diagnosis Sponsor: Taichung Veterans General Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests an AI-powered 3D imaging model to improve detection of cancer spread in patients with stage II-III rectal cancer. Researchers will analyze existing CT and MRI scans from 1,500 patients to see if the AI can predict whether the cancer has reached the edge of the tissue removed during surgery. The goal is to help doctors plan more precise treatments.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
AI-Assisted 3D Imaging Model
What this could lead to
If successful, this AI tool could help doctors more accurately detect if rectal cancer has spread to nearby tissues, leading to better surgical planning and outcomes.
What could go wrong
This is a retrospective study using existing images, not a real-time test. The AI may not perform as well in different hospitals or with different scanners.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,500 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2025

An estimate. Start dates often move.

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of adult patients (≥18 years) diagnosed with stage II-III locally advanced rectal cancer (LARC) without distant metastasis (M0), who received care at Taichung Veterans General Hospital (TVGH), Taiwan. Eligible participants have adequate physical status (ASA I-III) to undergo standard treatment and surgery, no history of other malignancies or major diseases affecting tumor assessment within the past three years, and complete medical records including CT and MRI imaging. Patients with stage I or IV disease, insufficient physical status, major comorbidities, or incomplete imaging/medical records are excluded.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosed with rectal cancer, clinical stage II-III, with no distant metastasis (M0) * Age over 18 years, with adequate physical status classified as American Society of Anesthesiologists (ASA) I-III, capable of receiving treatment and surgery * No history of other malignancies or major diseases affecting study assessment within the past three years. * Complete medical records, including available CT and MRI imaging. Exclusion Criteria: * Patients with clinical stage I or IV rectal cancer. * Age under 18 years, or physical status not meeting American Society of Anesthesiologists (ASA) I-III criteria, unable to undergo surgery or related treatment. * Presence of other major diseases or malignancies affecting tumor assessment (e.g., diagnosis of another malignancy within the past three years, uncontrolled cardiovascular disease). * Incomplete medical records or imaging data, including missing required CT or MRI images.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for General surgery are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

neoplasm rectal cancer rectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

General surgery Medical informatics Oncology

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Taichung Veterans General Hospital

    Taichung, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.